WARD COVID-19
Study design:
Observational study
Sample size:
Up to 300 participants
Study Sites
Rigshospitalet, Bispebjerg Hospital, Hvidovre Hospital, Nordsjællands Hospital (Hillerød), Sjællands University Hosptial (Køge), Odense University Hospital, Aalborg University Hospital.
Inclusion criteria
Adult patients (from 18 years of age) admitted with a confirmed COVID-19 infection, where study inclusion is possible within 72 hours of admission OR within 48 hours of discharge from ICU to a medical ward, and at least one overnight stay expected.
Study Procedures
Included patients will be monitored with WARD equipment after hospital admission and will be monitored during hospitalization. Patients vital parameters are continuously monitored and visible outside of the patients room limiting patient contact and personal protective equipment (PPE) use.
Outcome
Primary outcome is the cumulative duration of physiological parameter deviations. Secondary outcome is the frequency of micro events, measured by continuous vital sign monitoring and as measured by EWS in the control group.
Primary Investigators
Katja Kjær Grønbæk, MD, PhD student
NCT:
NCT04724681